Bao G - Search Results

1

Synthesis and Preclinical Evaluation of Dual-Specific Probe Targeting Glypican-3 and Prostate-Specific Membrane Antigen for Hepatocellular Carcinoma PET Imaging.

Chen L, Cheng S, Zhu D, Bao G, Wang Z, Deng X, Liu X, Ma X, Zhao J, Zhu L, Zhu X. Chen L, et al. Among authors: bao g. Mol Pharm. 2025 Jan 6;22(1):209-220. doi: 10.1021/acs.molpharmaceut.4c00838. Epub 2024 Dec 10. Mol Pharm. 2025. PMID: 39655726

2

Nanobody: a promising toolkit for molecular imaging and disease therapy.

Bao G, Tang M, Zhao J, Zhu X. Bao G, et al. EJNMMI Res. 2021 Jan 19;11(1):6. doi: 10.1186/s13550-021-00750-5. EJNMMI Res. 2021. PMID: 33464410 Free PMC article. Review.

3

PET imaging of an optimized anti-PD-L1 probe ⁶⁸Ga-NODAGA-BMS986192 in immunocompetent mice and non-human primates.

Zhou H, Bao G, Wang Z, Zhang B, Li D, Chen L, Deng X, Yu B, Zhao J, Zhu X. Zhou H, et al. Among authors: bao g. EJNMMI Res. 2022 Jun 13;12(1):35. doi: 10.1186/s13550-022-00906-x. EJNMMI Res. 2022. PMID: 35695985 Free PMC article.

4

Inhibition of Poly(ADP-ribose) Polymerase Sensitizes [¹⁷⁷Lu]Lu-DOTAGA.(SA.FAPi)₂-Mediated Radiotherapy in Triple-Negative Breast Cancer.

Bao G, Zhou H, Zou S, Chen L, Zhang B, Wang Z, Moon ES, Zhao J, Roesch F, Zhu X. Bao G, et al. Mol Pharm. 2023 May 1;20(5):2443-2451. doi: 10.1021/acs.molpharmaceut.2c01051. Epub 2023 Apr 17. Mol Pharm. 2023. PMID: 37067162

5

Synthesis of novel DOTA-/AAZTA-based bifunctional chelators: Solution thermodynamics, peptidomimetic conjugation, and radiopharmaceutical evaluation.

Liu X, Chen L, Li Y, He C, Zhang X, Zhou H, Bao G, Zhu X, Xiang G, Ma X. Liu X, et al. Among authors: bao g. Biomed Pharmacother. 2023 Sep;165:115114. doi: 10.1016/j.biopha.2023.115114. Epub 2023 Jul 17. Biomed Pharmacother. 2023. PMID: 37467649 Free article.

6

Targeting CXCR4/CXCL12 axis via [¹⁷⁷Lu]Lu-DOTAGA.(SA.FAPi)₂ with CXCR4 antagonist in triple-negative breast cancer.

Bao G, Wang Z, Liu L, Zhang B, Song S, Wang D, Cheng S, Moon ES, Roesch F, Zhao J, Yu B, Zhu X. Bao G, et al. Eur J Nucl Med Mol Imaging. 2024 Jul;51(9):2744-2757. doi: 10.1007/s00259-024-06704-y. Epub 2024 Apr 8. Eur J Nucl Med Mol Imaging. 2024. PMID: 38587644 Free PMC article.

7

Nuclear Molecular Imaging for Evaluating T Cell Exhaustion.

Zhou H, Bao G, Zhao J, Zhu X. Zhou H, et al. Among authors: bao g. Mol Pharm. 2025 Jan 6;22(1):103-112. doi: 10.1021/acs.molpharmaceut.4c00970. Epub 2024 Nov 25. Mol Pharm. 2025. PMID: 39586059 Review.

8

Preclinical evaluation of radiolabeled tissue factor-targeted peptide for theranostics of hepatocellular carcinoma post percutaneous ethanol injection.

Zhang B, Wang P, Chen Q, Yang Y, Xiong F, Bao G, Yang J, Wang Z, Zhou H, Song S, Zou S, Kim DH, Yu B, Zhu X. Zhang B, et al. Among authors: bao g. Theranostics. 2024 Oct 28;14(19):7370-7382. doi: 10.7150/thno.102130. eCollection 2024. Theranostics. 2024. PMID: 39659572 Free PMC article.

9

Comprehensive analysis of tumor immune-related gene signature for predicting prognosis, immunotherapy, and drug sensitivity in bladder urothelial carcinoma.

Guo C, Jiang X, Zhang Y, Bao G. Guo C, et al. Among authors: bao g. Transl Cancer Res. 2024 Dec 31;13(12):6732-6752. doi: 10.21037/tcr-24-1053. Epub 2024 Dec 24. Transl Cancer Res. 2024. PMID: 39816541 Free PMC article.

10

Refinement of a meaning-centered counseling program for Chinese patients with advanced cancer: integrating cultural adaptation and implementation science approaches.

Lui F, Zhang Q, Bao GC, Narang B, Chen RY, Niu Y, Leng J, Breitbart W. Lui F, et al. Among authors: bao gc. BMC Health Serv Res. 2025 Jan 15;25(1):85. doi: 10.1186/s12913-024-12124-3. BMC Health Serv Res. 2025. PMID: 39815347 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,177 results

Search Page

Filters